Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Obesity Surgery

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11695-008-9696-3PMID 18820978PMCID PMC2854668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimizing the technological and informational relationship of the health care process and of the communication between physician and patient. The impact of Preventive Medicine and social marketing applied in Health Care on youth awareness–Preliminary study

  2011cited by this paper
• Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

  2009cited by this paper
• Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.

  2008cited by this paper
• Restoration of Acute Insulin Response in T2DM Subjects 1 Month After Biliopancreatic Diversion

  2008cited by this paper
• Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release

  2008cited by this paper
• Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

  2008cited by this paper
• Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35

  2008influential reference
• Improvement of Insulin Resistance After Obesity Surgery: A Comparison of Gastric Banding and Bypass Procedures

  2008influential reference
• Ileal Transposition Controls Diabetes as Well as Modified Duodenal Jejunal Bypass With Better Lipid Lowering in a Nonobese Rat Model of Type II Diabetes by Increasing GLP-1

  2008cited by this paper
• Bariatric Surgery: The Past, Present, and Future

  2008cited by this paper
• Effect of Laparoscopic Mini-Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI >35 and <35 kg/m2

  2008cited by this paper
• Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance

  2008cited by this paper
• Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

  2008influential reference
• The Effect of Laparoscopic Gastric Banding Surgery on Plasma Levels of Appetite-Control, Insulinotropic, and Digestive Hormones

  2008cited by this paper
• Circulating Peptide YY, Weight Loss, and Glucose Homeostasis After Gastric Bypass Surgery in Morbidly Obese Subjects

  2008cited by this paper
• Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials

  2008cited by this paper
• Effects of bariatric surgery on mortality in Swedish obese subjects.

  2007cited by this paper
• Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes

  2007cited by this paper
• Resolution of Diabetes Mellitus and Metabolic Syndrome following Roux-en-Y Gastric Bypass and a Variant of Biliopancreatic Diversion in Patients with Morbid Obesity

  2007cited by this paper
• Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass

  2007cited by this paper
• How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.

  2007cited by this paper
• The physiology of glucagon-like peptide 1.

  2007cited by this paper
• The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.

  2007cited by this paper
• Peptide YY and Glucagon-like Peptide-1 in Morbidly Obese Patients Before and After Surgically Induced Weight Loss

  2007cited by this paper
• Bariatric Surgery Utilization and Outcomes in 1998 and 2004

  2007cited by this paper
• Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial.

  2007cited by this paper
• Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.

  2007cited by this paper
• Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.

  2007influential reference
• Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.

  2007influential reference
• New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery

  2007cited by this paper
• Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.

  2007cited by this paper
• Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function

  2006cited by this paper
• PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.

  2006influential reference
• Obese Subjects Respond to the Stimulatory Effect of the Ghrelin Agonist Growth Hormone‐Releasing Peptide‐2 on Food Intake

  2006cited by this paper
• Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

  2006cited by this paper
• GLP-1 and Changes in Glucose Tolerance following Gastric Bypass Surgery in Morbidly Obese Subjects

  2006influential reference
• Serum Ghrelin, Leptin and Adiponectin Levels before and after Weight Loss: Comparison of Three Methods of Treatment – A Prospective Study

  2006cited by this paper
• Short-term Changes in Insulin Resistance following Weight Loss Surgery for Morbid Obesity: Laparoscopic Adjustable Gastric Banding versus Laparoscopic Roux-en-Y Gastric Bypass

  2006influential reference
• Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

  2006cited by this paper
• Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery

  2006influential reference
• The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes

  2006cited by this paper
• Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels

  2006cited by this paper
• Peptide YY Levels Are Elevated After Gastric Bypass Surgery

  2006cited by this paper
• Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice.

  2006cited by this paper
• Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety

  2006cited by this paper
• Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

  2006cited by this paper
• 20: Laparoscopic Adjustable Gastric Banding versus Laparoscopic Roux-en-Y Gastric Bypass: 5 years results of a prospective randomized trial

  2006cited by this paper
• Changes in Glucagon-like Peptide-1 (GLP-1) Secretion after Biliopancreatic Diversion or Vertical Banded Gastroplasty in Obese Subjects

  2005influential reference
• Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery.

  2005cited by this paper
• Incretins, diabetes, and bariatric surgery: a review.

  2005cited by this paper
• Early Improvement of Glucose Tolerance after Ileal Transposition in a Non-obese Type 2 Diabetes Rat Model

  2005cited by this paper
• Loss of Insulin Resistance after Roux-en-Y Gastric Bypass Surgery: a Time Course Study

  2005influential reference
• Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.

  2005cited by this paper
• Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.

  2005cited by this paper
• Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.

  2005cited by this paper
• A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin

  2005cited by this paper
• Ghrelin increases food intake in obese as well as lean subjects

  2004cited by this paper
• The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism

  2004cited by this paper
• Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

  2004cited by this paper
• The Enteroinsular Axis and the Recovery from Type 2 Diabetes after Bariatric Surgery

  2004cited by this paper
• Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies.

  2004cited by this paper
• Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.

  2004cited by this paper
• Hormonal Changes after Roux-en Y Gastric Bypass for Morbid Obesity and the Control of Type-II Diabetes Mellitus

  2004cited by this paper
• Circulation and Degradation of GIP and GLP-1

  2004influential reference
• Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.

  2004cited by this paper
• Bariatric surgery: a systematic review and meta-analysis.

  2004cited by this paper
• Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis.

  2004cited by this paper
• Short-term effects of gastric bypass surgery on circulating ghrelin levels.

  2004cited by this paper
• Glycemic Control in Diabetic Patients after Bariatric Surgery

  2004cited by this paper
• Incretins, insulin secretion and Type 2 diabetes mellitus

  2004cited by this paper
• Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease

  2004cited by this paper
• Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.

  2003cited by this paper
• The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.

  2003cited by this paper
• One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes: a randomized trial.

  2003cited by this paper
• Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus

  2003cited by this paper
• Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.

  2003cited by this paper
• Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis*

  2003cited by this paper
• Improved beta-cell function after standardized weight reduction in severely obese subjects.

  2003cited by this paper
• Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.

  2003cited by this paper
• Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.

  2003cited by this paper
• Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

  2003cited by this paper
• Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans.

  2003cited by this paper
• Inhibition of food intake in obese subjects by peptide YY3-36.

  2003cited by this paper
• Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery.

  2003cited by this paper
• Enhancing incretin action for the treatment of type 2 diabetes.

  2003influential reference
• Gut hormone PYY3-36 physiologically inhibits food intake

  2002cited by this paper
• Effects of obesity surgery on non-insulin-dependent diabetes mellitus.

  2002cited by this paper
• Bariatric surgery and long-term control of morbid obesity.

  2002cited by this paper
• Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.

  2002cited by this paper
• Mechanisms in the Development of Type 2 Diabetes Mellitus

  2002cited by this paper
• Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

  2002cited by this paper
• Leptin Signaling, Adiposity, and Energy Balance

  2002cited by this paper
• Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

  2002cited by this paper
• Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

  2001cited by this paper
• The insulin tolerance test in morbidly obese patients undergoing bariatric surgery.

  2001cited by this paper
• Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.

  2001cited by this paper
• The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction

  2001cited by this paper
• Serum Leptin Levels After Bariatric Surgery Across a Range of Glucose Tolerance from Normal to Diabetes

  2001cited by this paper
• Glucagon receptors on human islet cells contribute to glucose competence of insulin release

  2000cited by this paper
• Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance

  2000cited by this paper

• Role of metabolic surgery in remission of type 2 diabetes mellitus in patients with obesity

  2023cites this paper
• First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations

  2023cites this paper
• Pregnancy after Bariatric Surgery: Nutrition Recommendations and Glucose Homeostasis: A Point of View on Unresolved Questions

  2023cites this paper
• Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21

  2023cites this paper
• Single anastomosis duodeno-ileal bypass with sleeve gastrectomy generates sustained improvement of glycemic control compared with sleeve gastrectomy in the diet-induced obese rat model

  2023cites this paper
• The many faces of diabetes. Is there a need for re-classification? A narrative review

  2022cites this paper
• Dietética

  2021cites this paper
• Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals

  2021cites this paper
• Optimal Surgical Treatment for Type 2 Diabetes: Sleeve Gastrectomy or Gastric Bypass?

  2021cites this paper
• The effects of Glucagon Like Peptide-1 (GLP-1) on cardiac remodelling: exploring the role of medication and physiological modulation after metabolic surgery: a narrative review.

  2021cites this paper
• Hyperinsulinemic Hypoglycemia after Bariatric Surgery

  2020cites this paper
• Comparison of Glycemic Status and Insulin Resistance before and after Sleeve Gastrectomy in Morbid Obese Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• 15 Can Bariatric or Metabolic Surgery Cure Type 2 Diabetes ?

  2019cites this paper
• Bariatric surgery in diabetes Mellitus type 2: predictors of remission, outcome and guidelines.

  2019cites this paper
• Dietary supplementation with Camu-Camu versus sleeve gastrectomy in Wistar rats weight control.

  2019cites this paper
• Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery

  2018cites this paper
• Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass

  2018cites this paper
• Long-term repercussions of Roux-en-Y gastric bypass in a low-income population: assessment ten years after surgery

  2018cites this paper
• Initial outcomes of one anastomosis gastric bypass at a single institution

  2018cites this paper
• The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy

  2018cites this paper
• Kidney transplant in patients with abnormal bladder: Experience of tertiary care center in developing country-Is the outcome same?

  2018cites this paper
• Long-term repercussions of Roux-en-Y gastric bypass in a low-income population: assessment ten years after surgery.

  2018cites this paper
• Insulin sensitivity is mediated by glucose in the hepatoportal region in the rat

  2017cites this paper
• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress

  2017cites this paper
• Sleeve Gastrectomy in Canine: Effect on Weight Loss, Inflammation andOxidative Stress Markers while Leaving Blind Intestinal Loop in Place

  2017cites this paper
• Ist Diabetes heilbar durch bariatrische Chirurgie? – Mechanismen der Verbesserung der diabetischen Stoffwechsellage durch chirurgische Adipositastherapie –

  2017cites this paper
• Small Bowel Target Devices and Techniques.

  2017cites this paper
• PROTOCOLS FOR PERIOPERATIVE NUTRITIONAL CARE PRACTICE IN ACCREDITED BARIATRIC SURGICAL CENTERS: A SURVEY OF CURRENT PRACTICE

  2017cites this paper
• Neuroendocrine mechanisms underlying bariatric surgery: Insights from human studies and animal models

  2017cites this paper
• Adipositastherapie – Is it possible to cure diabetes mellitus with bariatric surgery ? – Mechanisms of improvement of diabetes by bariatric surgery –

  2017cites this paper
• Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?

  2016cites this paper
• Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery.

  2016cites this paper
• Total gastrectomy improves glucose metabolism on gastric cancer patients: a nationwide population-based study.

  2016cites this paper
• SIMULTANEOUS DEBULKING OF GREAT OMENTUM LIKE A PALLIATIVE STAGE OF METABOLIC SYNDROM AND SIMULTANEOUS DEBULKING OF GREAT OMENTUM LIKE A PALLIATIVE STAGE OF METABOLIC SYNDROM AND OBESITY TREATMENT

  2016cites this paper
• Impact of Sleeve Gastrectomy on Type 2 Diabetes Mellitus, Gastric Emptying Time, Glucagon-Like Peptide 1 (GLP-1), Ghrelin and Leptin in Non-morbidly Obese Subjects with BMI 30–35.0 kg/m2: a Prospective Study

  2016cites this paper
• Effects of gastric bypass on FoxO1 expression in the liver and pancreas of diabetic rats

  2016cites this paper
• The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats

  2016cites this paper
• Type 2 Diabetes Mellitus remission eighteen months after Roux-en-Y gastric bypass.

  2016cites this paper
• Type 2 Diabetes Mellitus remission eighteen months after Roux-enY gastric bypass

  2016cites this paper
• No change in serum incretins levels but rise of leptin levels after smoking cessation: a pilot study.

  2016cites this paper
• Surgical cure for type 2 diabetes by foregut or hindgut operations: a myth or reality? A systematic review

  2016cites this paper
• Laparoscopic jejunoileal side-to-side anastomosis for the treatment of type 2 diabetes mellitus in Chinese patients with a body mass index of 24-32 kg/m2.

  2016cites this paper
• Сравнительный анализ эффективности лапароскопической рукавной резекции желудка и лапароскопического желудочного шунтирования у больных с сахарным диабетом 2-го типа и нарушением толерантности к глюкозе

  2016cites this paper
• 48 Effects of Bariatric Surgery on Diabetes

  2015cites this paper
• Bariatric surgery and diabetes remission: how far have we progressed?

  2015cites this paper
• Traiter le diabète de type 2 par la chirurgie bariatrique. Point de vue des médecins généralistes en Picardie

  2015cites this paper
• Bariatric surgery and diabetes remission: Who would have thought it?

  2015cites this paper
• A surgical model of short bowel syndrome induces a long-lasting increase in pancreatic beta-cell mass.

  2015cites this paper
• Prospective Randomized Comparison between Sleeve Gastrectomy with Side-to-Side Jejunoileal Anastomosis and Sleeve Gastrectomy in the Treatment of Morbid Obesity

  2015cites this paper
• Duodenal-jejunal exclusion improves insulin resistance in type 2 diabetic rats by upregulating the hepatic insulin signaling pathway.

  2015cites this paper
• [Consensus of diagnosis and treatment of obesity in women in reproductive age and climacterium].

  2015cites this paper
• Should metabolic surgery be offered in morbidly obese patients with type I diabetes?

  2015cites this paper
• Impact of weight loss achieved through gastric sleeve surgery with circulating level of ghrelin hormone in obese Iraqi subjects.

  2015cites this paper
• Effect of Modified Roux-en-Y Gastric Bypass Surgery on GLP-1, GIP in Patients with Type 2 Diabetes Mellitus

  2015cites this paper
• Cirugía de Diabetes Tipo 1 y 2

  2015influential citation
• Influence of gastric plication on course of diabetes mellitus in rats

  2015cites this paper
• 2 Nutrition in Clinical Practice XX ( X ) Metabolic and Bariatric Surgery ( ASMBS ) Medical Guidelines for Clinical Practice for the Perioperative Nutritional , Metabolic , and Nonsurgical Support of the Bariatric Surgery

  2014cites this paper
• Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m2 and higher than 35 kg/m2 in a 3-year observation period

  2014cites this paper
• Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients?

  2014cites this paper
• Short-Term Outcomes of Laparoscopic Single Anastomosis Gastric Bypass (LSAGB) for the Treatment of Type 2 Diabetes in Lower BMI (<30 kg/m2) Patients

  2014cites this paper
• Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy.

  2014cites this paper
• Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus.

  2014cites this paper
• Regulation of glucose homeostasis by GLP-1.

  2014cites this paper
• Hypoglycemia after Roux-en-Y Gastric Bypass Surgery

  2014cites this paper
• La chirurgie bariatrique dans le contrôle du syndrome métabolique : facteurs clinico-biologiques influençant les résultats

  2014cites this paper
• Relationship between gut hormones and glucose homeostasis after bariatric surgery

  2014cites this paper
• Nutrition and metabolic support recommendations for the bariatric patient.

  2014cites this paper
• The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model.

  2014cites this paper
• Comparison of the Effectiveness of Four Bariatric Surgery Procedures in Obese Patients with Type 2 Diabetes: A Retrospective Study

  2014cites this paper
• The environmenT wiThin: HOw guT mICRObIOTA mAy INFLuENCE mETAbOLIsm ANd bOdy COmPOsITION

  2013cites this paper
• Duodenal-Jejunal Bypass Improves Glycemia and Decreases SGLT1-Mediated Glucose Absorption in Rats With Streptozotocin-Induced Type 2 Diabetes

  2013cites this paper
• Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.

  2013cites this paper
• Epidermal growth factor can optimize a serum-free culture system for bone marrow stem cell proliferation in a miniature pig model

  2013cites this paper
• Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus

  2013cites this paper
• Evaluation of Weight Loss Failure, Medical Outcomes, and Personal Experiences after Roux-en-Y Gastric Bypass: A Critical Analysis

  2013cites this paper
• Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass?

  2013cites this paper
• Influence of diabetes surgery on gut hormones and incretins.

  2013cites this paper
• Ghrelin in obesity, physiological and pharmacological considerations.

  2013cites this paper
• Metabolic surgery for type 2 diabetes: efficacy and risks

  2013cites this paper
• Glucagon like peptide-1 (GLP-1) dynamics following bariatric surgery: a Signpost to a new frontier.

  2013cites this paper
• TWO Regulation of Glucose Homeostasis by GLP-1

  2013cites this paper
• Efeitos da derivação duodenojejunal em ratos wistar portadores de obesidade induzida pela dieta de cafeteria

  2013influential citation
• Evolução clínica a longo prazo de obesos graves diabéticos e não diabéticos, submetidos à derivação gástrica em Y de Roux/DGYR

  2013cites this paper
• Incretins: new targets for the prevention of diabetes and obesity

  2013cites this paper
• Preoperative Fasting Plasma C-Peptide Level May Help to Predict Diabetes Outcome After Gastric Bypass Surgery

  2013cites this paper
• Mathematical Models of Insulin-Glucose Regulation: an Important Tool for a Better Understanding of Diabetes

  2013influential citation
• Six Months Results of the Duodenal-Jejunal Bypass Liner for the Treatment of Obesity and Type 2 Diabetes

  2013cites this paper
• Effects of sleeve gastrectomy on parameters of lipid and glucose metabolism in obese women – 6 months after operation

  2012cites this paper
• CALL PAPERS Integrative Aspects of Energy Homeostasis and Metabolic Diseases Isolated duodenal exclusion increases energy expenditure and improves glucose homeostasis in diet-induced obese rats

  2012cites this paper
• Integrative Aspects of Energy Homeostasis and Metabolic Diseases Isolated duodenal exclusion increases energy expenditure and improves glucose homeostasis in diet-induced obese rats

  2012cites this paper
• Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for the Treatment of Morbid Obesity and Metabolic Diseases: a Promising Operation

  2012cites this paper
• Effect of Gastrointestinal Surgical Manipulation on Metabolic Syndrome: A Focus on Metabolic Surgery

  2012cites this paper
• Short-Term Changes of the Urine Metabolome After Bariatric Surgery

  2012influential citation
• Bariatric surgery and T2DM improvement mechanisms: a mathematical model

  2012influential citation
• Sleeve Gastrectomy with Jejunal Bypass for the Treatment of Type 2 Diabetes Mellitus in Patients with Body Mass Index <35 kg/m2. A cohort study

  2012cites this paper
• Effect of Laparoscopic Roux-en-Y Gastroenterostomy with BMI < 35 kg/m2 in Type 2 Diabetes Mellitus

  2012cites this paper
• Metabolic Improvements in Obese Type 2 Diabetes Subjects Implanted for 1 Year with an Endoscopically Deployed Duodenal–Jejunal Bypass Liner

  2012cites this paper
• Comparison of Markov Chain Monte Carlo and Generalized Least Square Methods on a Model of Glucose / Insulin Dynamics with GLP 1-DPP 4 Interaction

  2012cites this paper
• Isolated duodenal exclusion increases energy expenditure and improves glucose homeostasis in diet-induced obese rats.

  2012cites this paper
• Statistical evaluation of a glucose/insulin nonlinear differential equation model with classical and Bayesian procedures

  2012cites this paper